Nutrition and Degenerative Brain Dysfunctions
DOI:
https://doi.org/10.14738/aivp.111.13720Keywords:
prions, milfolded proteins, brain disorders, nucleotides, mushroom nutritionAbstract
The aim of the present mini review is to describe the nutritional role on the onset of brain neurodegenerative pathologies, some of genetic origin, others transferred from animals to humans. An outline is given on some pathophysiological mechanisms and nutrition with emphasis on nucleotide nutrition and mushrooms as foods or supplements on retarding ageing and preventing neurodegenerative diseases. Prions, prionoids and protein misfolding disorders are described as responsible for several neurodegenerative proteinopathies. Mention is made on cellular proteostasis network and translocation of proteins from the cytosol across membranes, scrutinised by molecular chaperones such as heat shock proteins, associated with cellular homeostasis in the critical regulation of neural physiological function. Some mechanisms preventing the formation of non-functional proteins relevant to neural physiological states and implications of cellular stress responses to human physiology and diseases are referred. The genetic regulation of protein synthesis plays an important role as transcriptional control in the regulation of gene expression being necessary to identify the molecular biomarkers and the misfolded proteins relevant to neural functions. It is evident that dietary nutrition aids in the prevention and remediation of neurologic symptoms and food components play an important role on the early prevention against neurodegenerative diseases while specific nutrients and nucleotides are considered essential for normal immune defences. A brief consideration is made on the microbiota-gut-brain axis signalling the interference and maintenance of homeostasis and brain physiology. Our previous research showed the potential for mushrooms to target neurogenesis through several bioactive compounds able to counteract neurodegenerative brain disorders.
References
Choi, J.; Yin, T.; Shinozaki, K.; Lampe, J.W.; Stevens, J.F.; Becker, L.B.; Kim, J. Comprehensive Analysis of Phospholipids in the Brain, Heart, Kidney, and Liver: Brain Phospholipids Are Least Enriched with Polyunsaturated Fatty Acids. Mol. Cell. Biochem. 2018, 442, 187–201, doi:10.1007/S11010-017-3203-X/FIGURES/11.
Schverer, M.; O’Mahony, S.M.; O’Riordan, K.J.; Donoso, F.; Roy, B.L.; Stanton, C.; Dinan, T.G.; Schellekens, H.; Cryan, J.F. Dietary Phospholipids: Role in Cognitive Processes across the Lifespan. Neurosci. Biobehav. Rev. 2020, 111, 183–193, doi:10.1016/J.NEUBIOREV.2020.01.012.
Wang, Y.; Pan, Y.; Li, H. What Is Brain Health and Why Is It Important? BMJ 2020, 371, doi:10.1136/BMJ.M3683.
Moura, C.S.; Lollo, P.C.B.; Morato, P.N.; Amaya-Farfan, J. Dietary Nutrients and Bioactive Substances Modulate Heat Shock Protein (HSP) Expression: A Review. Nutrients 2018, 10, doi:10.3390/NU10060683.
Mccleery, J.; Abraham, R.P.; Denton, D.A.; Rutjes, A.W.S.; Chong, L.Y.; Al-Assaf, A.S.; Griffith, D.J.; Rafeeq, S.; Yaman, H.; Malik, M.A.; et al. Vitamin and Mineral Supplementation for Preventing Dementia or Delaying Cognitive Decline in People with Mild Cognitive Impairment. Cochrane Database Syst. Rev. 2018, 2018, doi:10.1002/14651858.CD011905.PUB2/MEDIA/CDSR/CD011905/IMAGE_N/NCD011905-CMP-003-01.PNG.
Kock, R.; Caceres-Escobar, H. Situation Analysis on the Roles and Risks of Wildlife in the Emergence of Human Infectious Diseases; 2022;
Hill, A.F.; Desbruslais, M.; Joiner, S.; Sidle, K.C.L.; Gowland, I.; Collinge, J.; Doey, L.J.; Lantos, P. The Same Prion Strain Causes VCJD and BSE. Nature 1997, 389, 448–450, doi:10.1038/38925.
Prusiner, S.B. Novel Proteinaceous Infectious Particles Cause Scrapie. Science (80-. ). 1982, 216, 136–144, doi:10.1126/SCIENCE.6801762.
Ruffini, N.; Klingenberg, S.; Schweiger, S.; Gerber, S. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale. Cells 2020, 9, 2642, doi:10.3390/CELLS9122642.
Brown, P.; Bradley, R. 1755 and All That: A Historical Primer of Transmissible Spongiform Encephalopathy. BMJ 1998, 317, 1688–1692, doi:10.1136/BMJ.317.7174.1688.
Hadlow, W.J. Scrapie and Kuru. Lancet 1959, 274, 289–290, doi:10.1016/S0140-6736(59)92081-1.
Gajdusek,D.C. Nobel Lecture Available online: https://www.nobelprize.org/prizes/medicine/1976/gajdusek/lecture/ (accessed on14 eptember 2022).
Collinge, J.; Whitfield, J.; McKintosh, E.; Frosh, A.; Mead, S.; Hill, A.F.; Brandner, S.; Thomas, D.; Alpers, M.P. A Clinical Study of Kuru Patients with Long Incubation Periods at the End of the Epidemic in Papua New Guinea. Philos. Trans. R. Soc. 2008, 363, 3725, doi:10.1098/RSTB.2008.0068.
European Commission Commission Regulation (Eu) 2021/1372 of 17 August 2021. Off. J. Eur. Union 2021, 64.
Hope, J.; Wood, S.C.E.R.; Birkett, C.R.; Chong, A.; Bruce, M.E.; Cairns, D.; Goldmann, W.; Hunter, N.; Bostock, C.J. Molecular Analysis of Ovine Prion Protein Identifies Similarities between BSE and an Experimental Isolate of Natural Scrapie, CH 1641. J. Gen. Virol. 1999, 80, 1–4, doi:10.1099/0022-1317-80-1-1/CITE/REFWORKS.
Chalupa, W. Production of Animal Protein from Nonprotein Nitrogen Chemicals. Adv. Exp. Med. Biol. 1978, 105, 473–495, doi:10.1007/978-1-4684-3366-1_25/COVER.
Taylor, D.M. Bovine Spongiform Encephalopathy and Its Association with the Feeding of Ruminant-Derived Protein. Dev Biol Stand 1993, 80, 215–224.
Zhang, H.; Greenwood, D.C.; Risch, H.A.; Bunce, D.; Hardie, L.J.; Cade, J.E. Meat Consumption and Risk of Incident Dementia: Cohort Study of 493,888 UK Biobank Participants. Am. J. Clin. Nutr. 2021, 114, 175–184, doi:10.1093/AJCN/NQAB028.
Magaraggia, I.; Kuiperes, Z.; Schreiber, R. Improving Cognitive Functioning in Major Depressive Disorder with Psychedelics: A Dimensional Approach. Neurobiol. Learn. Mem. 2021, 183, doi:10.1016/J.NLM.2021.107467.
Adams, C.J.; Kopp, M.C.; Larburu, N.; Nowak, P.R.; Ali, M.M.U. Structure and Molecular Mechanism of ER Stress Signaling by the Unfolded Protein Response Signal Activator IRE1. Front. Mol. Biosci. 2019, 6, 11, doi:10.3389/FMOLB.2019.00011/XML/NLM.
Chiti, F.; Dobson, C.M. Protein Misfolding, Functional Amyloid, and Human Disease. Annu. Rev. Biochem. 2006, 75, 333–366, doi:10.1146/annurev.biochem.75.101304.123901.
Guest, W.C.; Silverman, J.M.; Pokrishevsky, E.; O’Neill, M.A.; Grad, L.I.; Cashman, N.R. Generalization of the Prion Hypothesis to Other Neurodegenerative Diseases: An Imperfect Fit. J. Toxicol. Environ. Health 2011, 74, 1433–1459, doi:10.1080/15287394.2011.618967.
Götz, J.; Halliday, G.; Nisbet, R.M. Molecular Pathogenesis of the Tauopathies. Annu. Rev. Pathol. Mech. Dis. 2019, 14, 239–261, doi:10.1146/annurev-pathmechdis-012418-012936.
Andreasen, M.; Lorenzen, N.; Otzen, D. Interactions between Misfolded Protein Oligomers and Membranes: A Central Topic in Neurodegenerative Diseases? Biochim. Biophys. Acta 2015, 1848, 1897–1907, doi:10.1016/J.BBAMEM.2015.01.018.
Kraus, A.; Groveman, B.R.; Caughey, B. Prions and the Potential Transmissibility of Protein Misfolding Diseases*. Annu. Rev. Microbiol. 2013, 67, 543–564, doi:10.1146/ANNUREV-MICRO-092412-155735.
Lee, B.D.; Koonin, E. V. Viroids and Viroid-like Circular RNAs: Do They Descend from Primordial Replicators? Life 2022, 12, 103, doi:10.3390/LIFE12010103.
Baiardi, S.; Rossi, M.; Capellari, S.; Parchi, P. Recent Advances in the Histo-Molecular Pathology of Human Prion Disease. Brain Pathol. 2019, 29, 278–300, doi:10.1111/BPA.12695.
Yoshida, K.; Higuchi, K.; Ikeda, S. [Can Prion-like Propagation Occur in Neurodegenerative Diseases?: In View of Transmissible Systemic Amyloidosis]. Brain Nerve 2012, 64, 665–674. 495
Verma, A. Prions, Prion-like Prionoids, and Neurodegenerative Disorders. Ann. Indian Acad. Neurol. 2016, 19, 169–174, doi:10.4103/0972-2327.179979.
Kumar, A.; Janelidze, S.; Stomrud, E.; Palmqvist, S.; Hansson, O.; Mattsson-Carlgren, N. β-Amyloid–Dependent and –Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease. Neurology 2022, 99, e476–e487, doi:10.1212/WNL.0000000000200605.
Ritchie, D.L.; Barria, M.A. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases? Biomolecules 2021, 11, 207, doi:10.3390/BIOM11020207.
Scheckel, C.; Aguzzi, A. Prions, Prionoids and Protein Misfolding Disorders. Nat. Rev. Genet. 2018, 19, 405–418, doi:10.1038/s41576-018-0011-4.
Miller, M.A.; Zachary, J.F. Mechanisms and Morphology of Cellular Injury, Adaptation, and Death. Pathol. Basis Vet. Dis. 2017, 2–43, doi:10.1016/B978-0-323-35775-3.00001-1.
Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. The Endoplasmic Reticulum. In Molecular Biology of the Cell; Garland Science: New York, 2002.
Horne, J.E.; Brockwell, D.J.; Radford, S.E. Role of the Lipid Bilayer in Outer Membrane Protein Folding in Gram-Negative Bacteria. J. Biol. Chem. 2020, 295, 10340–10367, doi:10.1074/JBC.REV120.011473.
Marinko, J.T.; Huang, H.; Penn, W.D.; Capra, J.A.; Schlebach, J.P.; Sanders, C.R. Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis. Chem. Rev. 2019, 119, 5537–5606, doi:10.1021/ACS.CHEMREV.8B00532/ASSET/IMAGES/LARGE/CR-2018-00532P_0031.JPEG.
Ritossa, F.M. Experimental Activation of Specific Loci in Polytene Chromosomes of Drosophila. Exp. Cell Res. 1964, 35, 601–607, doi:10.1016/0014-4827(64)90147-8.
Fittipaldi, S.; Dimauro, I.; Mercatelli, N.; Caporossi, D. Role of Exercise-Induced Reactive Oxygen Species in the Modulation of Heat Shock Protein Response. Free Radic. Res. 2014, 48, 52–70, doi:10.3109/10715762.2013.835047.
Stetler, R.A.; Gan, Y.; Zhang, W.; Liou, A.K.; Gao, Y.; Cao, G.; Chen, J. Heat Shock Proteins: Cellular and Molecular Mechanisms in the Central Nervous System. Prog. Neurobiol. 2010, 92, 184–211, doi:10.1016/J.PNEUROBIO.2010.05.002.
Calabrese, V.; Cornelius, C.; Dinkova-Kostova, A.T.; Calabrese, E.J.; Mattson, M.P. Cellular Stress Responses, The Hormesis Paradigm, and Vitagenes: Novel Targets for Therapeutic Intervention in Neurodegenerative Disorders. Antioxid Redox Signal 2010, 13, 1763–1811, doi:10.1089/ars.2009.3074.
Wan, Q.; Song, D.; Li, H.; He, M. liang Stress Proteins: The Biological Functions in Virus Infection, Present and Challenges for Target-Based Antiviral Drug Development. Signal Transduct. Target. Ther. 2020, 5, 1–40, doi:10.1038/s41392-020-00233-4.
Zininga, T.; Ramatsui, L.; Shonhai, A. Heat Shock Proteins as Immunomodulants. Molecules 2018, 23, doi:10.3390/MOLECULES23112846.
Chen, Y.; Voegeli, T.S.; Liu, P.P.; Noble, E.G.; Curie, R.W. Heat Stock Paradox and a New Role of Heat Shock Proteins and Their Receptors as Anti-Inflammation Targets. Inflamm. Allergy - Drug Targets 2007, 6, 91–100, doi:10.2174/187152807780832274.
Fulda, S.; Gorman, A.M.; Hori, O.; Samali, A. Cellular Stress Responses: Cell Survival and Cell Death. Int. J. Cell Biol. 2010, 2010, doi:10.1155/2010/214074.
Lockshin, R.A.; Zakeri, Z. Programmed Cell Death and Apoptosis: Origins of the Theory. Nat. Rev. Mol. Cell Biol. 2001, 2, 545–550, doi:10.1038/35080097.
Gao, W.; Wang, X.; Zhou, Y.; Wang, X.; Yu, Y. Autophagy, Ferroptosis, Pyroptosis, and Necroptosis in Tumor Immunotherapy. Signal Transduct. Target. Ther. 2022, 7, 1–26, doi:10.1038/s41392-022-01046-3.
Kleijn, I.T.; Martinez-Segura, A.; Bertaux, F.; aint, M.; ramer, H.; Shahrezaei, V.; Marguerat, S. Growth-Rate-Dependent and Nutrient-Specific Gene Expression Resource Allocation in Fission Yeast. Life Sci. Alliance 2022, 5, doi:10.26508/LSA.202101223.
Tasaki, S.; Xu, J.; Avey, D.R.; Johnson, L.; Petyuk, V.A.; Dawe, R.J.; Bennett, D.A.; Wang, Y.; Gaiteri, C. Inferring Protein Expression Changes from MRNA in Alzheimer’s Dementia Using Deep Neural Networks. Nat. Commun. 2022, 13, 1–15, doi:10.1038/s41467-022-28280-1.
Lio, C.W.J.; Huang, S.C.C. Circles of Life: Linking Metabolic and Epigenetic Cycles to Immunity. Immunology 2020, 161, 165, doi:10.1111/IMM.13207.
Barber, T.M.; Valsamakis, G.; Mastorakos, G.; Hanson, P.; Kyrou, I.; Randeva, H.S.; Weickert, M.O. Dietary Influences on the Microbiota–Gut–Brain Axis. Int. J. Mol. Sci. 2021, 22, 3502, doi:10.3390/IJMS22073502.
Mao, X.Y.; Yin, X.X.; Guan, Q.W.; Xia, Q.X.; Yang, N.; Zhou, H.H.; Liu, Z.Q.; Jin, W.L. Dietary Nutrition for Neurological Disease Therapy: Current Status and Future Directions. Pharmacol. Ther. 2021, 226, doi:10.1016/J.PHARMTHERA.2021.107861.
Ramírez-Salazar, S.A.; Herren, C.; McCartney, J.; Ortiz García, J.G. Dietary Insights in Neurological Diseases. Curr. Neurol. Neurosci. Rep. 2021, 21, 1–11, doi:10.1007/S11910-021-01143-W/TABLES/2.
Mofatteh, M. Neurodegeneration and Axonal MRNA Transportation. Am. J. Neurodegener. Dis. 2021, 10, 1.
Buccitelli, C.; Selbach, M. MRNAs, Proteins and the Emerging Principles of Gene Expression Control. Nat. Rev. Genet. 2020, 21, 630–644, doi:10.1038/s41576-020-0258-4.
Vargas, J.N.S.; Sleigh, J.N.; Schiavo, G. Coupling Axonal MRNA Transport and Local Translation to Organelle Maintenance and Function. Curr. Opin. Cell Biol. 2022, 74, 97–103, doi:10.1016/J.CEB.2022.01.008.
Singh, R.; Sophiarani, Y. A Report on DNA Sequence Determinants in Gene Expression. Bioinformation 2020, 16, 422, doi:10.6026/97320630016422.
Condrat, C.E.; Thompson, D.C.; Barbu, M.G.; Bugnar, O.L.; Boboc, A.; Cretoiu, D.; Suciu, N.; Cretoiu, S.M.; Voinea, S.C. MiRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells 2020, 9, doi:10.3390/CELLS9020276.
Anand, R.; Sarmah, D.T.; Chatterjee, S. Extracting Proteins Involved in Disease Progression Using Temporally Connected Networks. BMC Syst. Biol. 2018, 12, 1–13, doi:10.1186/S12918-018-0600-Z/TABLES/5.
Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. The Shape and Structure of Proteins. In Molecular Biology of the Cell; Garland Science: New York, 2002.
Laham-Karam, N.; Pinto, G.P.; Poso, A.; Kokkonen, P. Transcription and Translation Inhibitors in Cancer Treatment. Front. Chem. 2020, 8, 276, doi:10.3389/FCHEM.2020.00276/XML/NLM.
Romero-Barrios, N.; Legascue, M.F.; Benhamed, M.; Ariel, F.; Crespi, M. Splicing Regulation by Long Noncoding RNAs. Nucleic Acids Res. 2018, 46, 2169–2184, doi:10.1093/NAR/GKY095.
Png, G.; Barysenka, A.; Repetto, L.; Navarro, P.; Shen, X.; Pietzner, M.; Wheeler, E.; Wareham, N.J.; Langenberg, C.; Tsafantakis, E.; et al. Mapping the Serum Proteome to Neurological Diseases Using Whole Genome Sequencing. Nat. Commun. 2021, 12, 1–12, doi:10.1038/s41467-021-27387-1.
Santos, R.; Ursu, O.; Gaulton, A.; Bento, A.P.; Donadi, R.S.; Bologa, C.G.; Karlsson, A.; Al-Lazikani, B.; Hersey, A.; Oprea, T.I.; et al. A Comprehensive Map of Molecular Drug Targets. Nat. Rev. Drug Discov. 2016, 16, 19–34, doi:10.1038/nrd.2016.230.
Ghadermarzi, S.; Li, X.; Li, M.; Kurgan, L. Sequence-Derived Markers of Drug Targets and Potentially Druggable Human Proteins. Front. Genet. 2019, 10, doi:10.3389/FGENE.2019.01075.
Zhang, S.; Pochini, L.; Galluccio, M. Heterologous (Over) Expression of Human SoLute Carrier (SLC) in Yeast: A Well-Recognized Tool for Human Transporter Function/Structure Studies. Life Sci. Educ. 2022, 12, 1206, doi:10.3390/LIFE12081206.
Bains, A.; Chawla, P.; Kaur, S.; Najda, A.; Fogarasi, M.; Fogarasi, S. Bioactives from Mushroom: Health Attributes and Food Industry Applications. Mater. (Basel, Switzerland) 2021, 14, doi:10.3390/MA14247640.
Oláh, J.; Szénási, T.; Lehotzky, A.; Norris, V.; Ovádi, J. Challenges in Discovering Drugs That Target the Protein–Protein Interactions of Disordered Proteins. Int. J. Mol. Sci. 2022, 23, doi:10.3390/IJMS23031550.
Trovato-Salinaro, A.; Siracusa, R.; Di Paola, R.; Scuto, M.; Fronte, V.; Koverech, G.; Luca, M.; Serra, A.; Toscano, M.A.; Petralia, A.; et al. Redox Modulation of Cellular Stress Response and Lipoxin A4 Expression by Coriolus Versicolor in Rat Brain: Relevance to Alzheimer’s Disease Pathogenesis. Neurotoxicology 2016, 53, 350–358, doi:10.1016/J.NEURO.2015.09.012.
Popa-Wagner, A.; Dumitrascu, D.; Capitanescu, B.; Petcu, E.; Surugiu, R.; Fang, W.H.; Dumbrava, D.A. Dietary Habits, Lifestyle Factors and Neurodegenerative Diseases. Neural Regen. Res. 2020, 15, 394–400, doi:10.4103/1673-5374.266045.
Poulose, S.M.; Miller, M.G.; Scott, T.; Shukitt-Hale, B. Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function. Adv. Nutr. 2017, 8, 804, doi:10.3945/AN.117.016261.
Kępka, A.; Ochocińska, A.; Borzym-Kluczyk, M.; Chojnowska, S.; Skorupa, E.; Przychodzeń, M.; Waszkiewicz, N. Healthy Food Pyramid as Well as Physical and Mental Activity in the Prevention of Alzheimer’s Disease. Nutrients 2022, 14, 1534, doi:10.3390/NU14081534.
Calfio, C.; Gonzalez, A.; Singh, S.K.; Rojo, L.E.; MacCioni, R.B. The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer’s Disease. J. Alzheimer’s Dis. 2020, 77, 33–51, doi:10.3233/JAD-200443.
Maccioni, R.B.; Calfío, C.; González, A.; Lüttges, V. Novel Nutraceutical Compounds in Alzheimer Prevention. Biomolecules 2022, 12, 249, doi:10.3390/BIOM12020249.
Trovato Salinaro, A.; Pennisi, M.; Di Paola, R.; Scuto, M.; Crupi, R.; Cambria, M.T.; Ontario, M.L.; Tomasello, M.; Uva, M.; Maiolino, L.; et al. Neuroinflammation and Neurohormesis in the Pathogenesis of Alzheimer’s Disease and Alzheimer-Linked Pathologies: Modulation by Nutritional Mushrooms. Immun. ageing 2018, 15, doi:10.1186/S12979-017-0108-1.
Bhat, B.A.; Almilaibary, A.; Mir, R.A.; Aljarallah, B.M.; Mir, W.R.; Ahmad, F.; Mir, M.A. Natural Therapeutics in Aid of Treating Alzheimer’s Disease: A Green Gateway Toward Ending Quest for Treating Neurological Disorders. Front. Neurosci. 2022, 16, doi:10.3389/FNINS.2022.884345.
Engelborghs, S.; Gilles, C.; Ivanoiu, A.; Vandewoude, M. Rationale and Clinical Data Supporting Nutritional Intervention in Alzheimer’s Disease. Acta Clin. Belg. 2014, 69, 17–24, doi:10.1179/0001551213Z.0000000006.
Moore, K.; Hughes, C.F.; Ward, M.; Hoey, L.; McNulty, H. Diet, Nutrition and the Ageing Brain: Current Evidence and New Directions. Proc. Nutr. Soc. 2018, 77, 152–163, doi:10.1017/S0029665117004177.
Parvez, M.K. Natural or Plant Products for the Treatment of Neurological Disorders: Current Knowledge. Curr. Drug Metab. 2017, 18, doi:10.2174/1389200218666170710190249.
Vauzour, D.; Camprubi-Robles, M.; Miquel-Kergoat, S.; Andres-Lacueva, C.; Bánáti, D.; Barberger-Gateau, P.; Bowman, G.L.; Caberlotto, L.; Clarke, R.; Hogervorst, E.; et al. Nutrition for the Ageing Brain: Towards Evidence for an Optimal Diet. Ageing Res. Rev. 2017, 35, 222–240, doi:10.1016/J.ARR.2016.09.010.
Flanagan, E.; Lamport, D.; Brennan, L.; Burnet, P.; Calabrese, V.; Cunnane, S.C.; de Wilde, M.C.; Dye, L.; Farrimond, J.A.; Emerson Lombardo, N.; et al. Nutrition and the Ageing Brain: Moving towards Clinical Applications. Ageing Res. Rev. 2020, 62, doi:10.1016/J.ARR.2020.101079.
El Soury, M.; Fornasari, B.E.; Carta, G.; Zen, F.; Haastert-Talini, K.; Ronchi, G. The Role of Dietary Nutrients in Peripheral Nerve Regeneration. Int. J. Mol. Sci. 2021, 22, doi:10.3390/IJMS22147417.
Baumel, B.S.; Doraiswamy, P.M.; Sabbagh, M.; Wurtman, R. Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review. Neurol. Ther. 2021, 10, 43–60, doi:10.1007/S40120-020-00227-Y.
Ding, H.; Reiss, A.B.; Pinkhasov, A.; Kasselman, L.J. Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer’s Disease, and Other Dementias. Medicina (B. Aires). 2022, 58, 1025, doi:10.3390/MEDICINA58081025.
Matijašević, D.; Pantić, M.; Stanisavljević, N.; Jevtić, S.; Rajić, N.; Lević, S.; Nedović, V.; Nikšić, M. Coriolus Versicolor Mushroom Grown on Selenium-Rich Zeolitic Tuff as a Potential Novel Food Supplement. Food Technol. Biotechnol. 2022, 60, 67–79, doi:10.17113/FTB.60.01.22.7172.
Pray, L.A. Discovery of DNA Structure and Function: Watson and Crick. Nat. Educ. 2008, 1, 100.
Umar, S. Intestinal Stem Cells. Curr. Gastroenterol. Rep. 2010, 12, 340–348, doi:10.1007/S11894-010-0130-3/TABLES/1.
Barker, N.; De Wetering, M. Van; Clevers, H. The Intestinal Stem Cell. Genes Dev. 2008, 22, 1856–1864, doi:10.1101/GAD.1674008.
Grimble, G.K.; Westwood, O.M. Nucleotides as Immunomodulators in Clinical Nutrition. Curr. Opin. Clin. Nutr. Metab. Care 2001, 4, 57–64, doi:10.1097/00075197-200101000-00011.
Jang, K.B.; Kim, S.W. Supplemental Effects of Dietary Nucleotides on Intestinal Health and Growth Performance of Newly Weaned Pigs. J. Anim. Sci. 2019, 97, 4875–4882, doi:10.1093/JAS/SKZ334.
Carver, J.D.; Allan Walker, W. The Role of Nucleotides in Human Nutrition. J. Nutr. Biochem. 1995, 6, 58–72, doi:10.1016/0955-2863(94)00019-I.
Van Buren, C.T.; Kulkarni, A.D.; Rudolph, F.B. The Role of Nucleotides in Adult Nutrition. J. Nutr. 1994, 124, 160S-164S, doi:10.1093/JN/124.SUPPL_1.160S.
Pizzini, R.P.; Kumar, S.; Kulkarni, A.D.; Rudolph, F.B.; Van Buren, C.T. Dietary Nucleotides Reverse Malnutrition and Starvation-Induced Immunosuppression. Arch. Surg. 1990, 125, 86–90, doi:10.1001/ARCHSURG.1990.01410130092012.
European Commission Commission Directive 2006/141/EC of 22 December 2006 Available online: http://data.europa.eu/eli/dir/2006/141/oj.
Ben, X.M. Nutritional Management of Newborn Infants: Practical Guidelines. World J. Gastroenterol. 2008, 14, 6133–6139, doi:10.3748/wjg.14.6133.
Sanchez Pozo, A. Dietary Nucleotides in Neurodegenerative Diseases. Biochem. Mol. Biol. J. 2015, 1, doi:10.21767/2471-8084.100001.
Wang, L.; Pooler, A.M.; Albrecht, M.A.; Wurtman, R.J. Dietary Uridine-5′-Monophosphate Supplementation Increases Potassium-Evoked Dopamine Release and Promotes Neurite Outgrowth in Aged Rats. J. Mol. Neurosci. 2005, 27, 137–145, doi:10.1385/JMN:27:1:137.
Dancey, C.P.; Attree, E.A.; Brown, K.F. Nucleotide Supplementation: A Randomised Double-Blind Placebo Controlled Trial of IntestAidIB in People with Irritable Bowel Syndrome [ISRCTN67764449]. Nutr. J. 2006, 5, 1–9, doi:10.1186/1475-2891-5-16/FIGURES/3.
D’amico, R.; Salinaro, A.T.; Fusco, R.; Cordaro, M.; Impellizzeri, D.; Scuto, M.; Ontario, M.L.; Dico, G. Lo; Cuzzocrea, S.; Di Paola, R.; et al. Hericium Erinaceus and Coriolus Versicolor Modulate Molecular and Biochemical Changes after Traumatic Brain Injury. Antioxidants (Basel, Switzerland) 2021, 10, doi:10.3390/ANTIOX10060898.
Yuan, J.P.; Zhao, S.Y.; Wang, J.H.; Kuang, H.C.; Liu, X. Distribution of Nucleosides and Nucleobases in Edible Fungi. J. Agric. Food Chem. 2008, 56, 809–815, doi:10.1021/JF0719205.
Phan, C.W.; Wang, J.K.; Cheah, S.C.; Naidu, M.; David, P.; Sabaratnam, V. A Review on the Nucleic Acid Constituents in Mushrooms: Nucleobases, Nucleosides and Nucleotides. Crit. Rev. Biotechnol. 2018, 38, 762–777, doi:10.1080/07388551.2017.1399102.
Groussin, M.; Mazel, F.; Alm, E.J. Co-Evolution and Co-Speciation of Host-Gut Bacteria Systems. Cell Host Microbe 2020, 28, 12–22, doi:10.1016/J.CHOM.2020.06.013.
Schluter, J.; Nadell, C.D.; Bassler, B.L.; Foster, K.R. Adhesion as a Weapon in Microbial Competition. ISME J. 2014, 9, 139–149, doi:10.1038/ismej.2014.174.
Putignani, L.; Del Chierico, F.; Petrucca, A.; Vernocchi, P.; Dallapiccola, B. The Human Gut Microbiota: A Dynamic Interplay with the Host from Birth to Senescence Settled during Childhood. Pediatr. Res. 2014, 76, 2–10, doi:10.1038/PR.2014.49.
Rai, S.N.; Mishra, D.; Singh, P.; Vamanu, E.; Singh, M.P. Therapeutic Applications of Mushrooms and Their Biomolecules along with a Glimpse of in Silico Approach in Neurodegenerative Diseases. Biomed. Pharmacother. 2021, 137, doi:10.1016/J.BIOPHA.2021.111377.
Doifode, T.; Giridharan, V. V.; Generoso, J.S.; Bhatti, G.; Collodel, A.; Schulz, P.E.; Forlenza, O. V.; Barichello, T. The Impact of the Microbiota-Gut-Brain Axis on Alzheimer’s Disease Pathophysiology. Pharmacol. Res. 2021, 164, 105314, doi:10.1016/J.PHRS.2020.105314.
Cryan, J.F.; O’riordan, K.J.; Cowan, C.S.M.; Sandhu, K. V.; Bastiaanssen, T.F.S.; Boehme, M.; Codagnone, M.G.; Cussotto, S.; Fulling, C.; Golubeva, A. V.; et al. The Microbiota-Gut-Brain Axis. Physiol. Rev. 2019, 99, 1877–2013, doi:10.1152/PHYSREV.00018.2018.
Yu, J.; Cheng, Q.; He, F.; Meng, F.; Yu, Y.; Xu, C.; Wen, X.; Hong, L.; Gao, J.; Li, J.; et al. Altered Intestinal Microbiomes and Lipid Metabolism in Patients With Prolonged Disorders of Consciousness. Front. Immunol. 2022, 13, 3396, doi:10.3389/FIMMU.2022.781148/BIBTEX.
Li, C.; Chen, J.; Li, S.C. Understanding Horizontal Gene Transfer Network in Human Gut Microbiota. Gut Abdel-Wahab, H. (2023). Inorganic Acids, Fluoridated Ethanol’s, and Some Fluoridated Saturated Hydrocarbons’ Stability and Bond Dissociation Pathog. 2020, 12, 1–20, doi:10.1186/S13099-020-00370-9/TABLES/1.
Guo, J.; Zhang, M.; Wang, H.; Li, N.; Lu, Z.; Li, L.; Hui, S.; Xu, H. Gut Microbiota and Short Chain Fatty Acids Partially Mediate the Beneficial Effects of Inulin on Metabolic Disorders in Obese Ob/Ob Mice. J. Food Biochem. 2022, 46, e14063, doi:10.1111/JFBC.14063.
O’Riordan, K.J.; Collins, M.K.; Moloney, G.M.; Knox, E.G.; Aburto, M.R.; Fülling, C.; Morley, S.J.; Clarke, G.; Schellekens, H.; Cryan, J.F. Short Chain Fatty Acids: Microbial Metabolites for Gut-Brain Axis Signalling. Mol. Cell. Endocrinol. 2022, 546, doi:10.1016/J.MCE.2022.111572.
Portincasa, P.; Bonfrate, L.; Vacca, M.; De Angelis, M.; Farella, I.; Lanza, E.; Khalil, M.; Wang, D.Q.H.; Sperandio, M.; Di Ciaula, A. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. Int. J. Mol. Sci. 2022, 23, doi:10.3390/IJMS23031105.
Kai, Y. Intestinal Villus Structure Contributes to Even Shedding of Epithelial Cells. Biophys. J. 2021, 120, 699–710, doi:10.1016/J.BPJ.2021.01.003.
Singh, S.; Sharma, P.; Pal, N.; Kumawat, M.; Shubham, S.; Sarma, D.K.; Tiwari, R.R.; Kumar, M.; Nagpal, R. Impact of Environmental Pollutants on Gut Microbiome and Mental Health via the Gut–Brain Axis. Microorganisms 2022, 10, 1457, doi:10.3390/MICROORGANISMS10071457.
Lew, S.Y.; Lim, S.H.; Lim, L.W.; Wong, K.H. Neuroprotective Effects of Hericium Erinaceus (Bull.: Fr.) Pers. against High-Dose Corticosterone-Induced Oxidative Stress in PC-12 Cells. BMC Complement. Med. Ther. 2020, 20, 1–16, doi:10.1186/S12906-020-03132-X/FIGURES/8.
Yadav, S.K.; Ir, R.; Jeewon, R.; Doble, M.; Hyde, K.D.; Kaliappan, I.; Jeyaraman, R.; Reddi, R.N.; Krishnan, J.; Li, M.; et al. A Mechanistic Review on Medicinal Mushrooms-Derived Bioactive Compounds: Potential Mycotherapy Candidates for Alleviating Neurological Disorders. Planta Med. 2020, 86, 1161–1175, doi:10.1055/A-1177-4834.
Sharma, A.; Sharma, A.; Tripathi, A. Biological Activities of Pleurotus Spp. Polysaccharides: A Review. J. Food Biochem. 2021, 45, e13748, doi:10.1111/JFBC.13748.
Ferreiro, E.; Pita, I.R.; Mota, S.I.; Valero, J.; Ferreira, N.R.; Fernandes, T.; Calabrese, V.; Fontes-Ribeiro, C.A.; Pereira, F.C.; Rego, A.C. Coriolus Versicolor Biomass Increases Dendritic Arborization of Newly-Generated Neurons in Mouse Hippocampal Dentate Gyrus. Oncotarget 2018, 9, 32929–32942, doi:10.18632/ONCOTARGET.25978.
García-Sanmartín, J.; Bobadilla, M.; Mirpuri, E.; Grifoll, V.; Pérez-Clavijo, M.; Martínez, A. Agaricus Mushroom-Enriched Diets Modulate the Microbiota-Gut-Brain Axis and Reduce Brain Oxidative Stress in Mice. Antioxidants 2022, 11, doi:10.3390/ANTIOX11040695.
Kushairi, N.; Phan, C.W.; Sabaratnam, V.; David, P.; Naidu, M. Lion’s Mane Mushroom, Hericium Erinaceus (Bull.: Fr.) Pers. Suppresses H 2 O 2-Induced Oxidative Damage and LPS-Induced Inflammation in HT22 Hippocampal Neurons and BV2 Microglia. Antioxidants (Basel, Switzerland) 2019, 8, doi:10.3390/ANTIOX8080261.
Calabrese, V.; Ontario, M. Mushroom Nutrition In Neurodegenerative Syndromes. Clin. J. Mycol. 2022, 6, doi:10.54225/CJM.VOL6.3.71520.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Bell, V., Fernandes, T. H.
This work is licensed under a Creative Commons Attribution 4.0 International License.
